Eli Lilly And Co
About Eli Lilly And Co
Eli Lilly and Company is a global pharmaceutical leader dedicated to discovering and delivering innovative medicines that make life better for people around the world. With a robust portfolio addressing diabetes, oncology, neuroscience, and immunology, Lilly combines cutting-edge research with a commitment to patient care. The company's mission is to unite caring with discovery to create medicines that improve lives globally.
Eli Lilly Is Stockpiling Weight Loss Pills
Eli Lilly (NYSE: LLY) has accumulated $1.5B USD of pre-launch inventory of their weight loss pill orforglipron according to new filings.
Eli Lilly And Nvidia Form New Drug Discovery Partnership
Nvidia (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have formed a partnership focused on using artificial intelligence for developing new drugs and therapeutics.
Eli Lilly Is Betting On Brian Armstrong’s Longevity Drug Development Startup
Eli Lilly (NYSE: LLY) has made a strategic investment of $45 million into longevity startup NewLimit at a valuation of approximately $1.6 billion.
Eli Lilly Has A New Breakthrough Weight Loss Pill
Eli Lilly (NYSE: LLY) has announced new positive clinical results from their Phase III clinical trial for their novel weight loss pill orforglipron.
Eli Lilly Is Getting Into The Venture Capital Business
Eli Lilly (NYSE: LLY) has launched a new venture capital fund with a16z known as the Biotech Ecosystem Venture Fund.
